Questionnaires on Nomophobia, Perceived Stress, Body Image, and Food Addiction; Body Composition and Anthropometric Measurements via Bioelectrical Impedance Analysis
Questionnaires on Nomophobia, Perceived Stress, Body Image, and Food Addiction; Body Composition and Anthropometric Measurements via Bioelectrical Impedance Analysis: Participants will complete self-report questionnaires including the Nomophobia Questionnaire (NMP-Q), Perceived Stress Scale (PSS-10), Body Image Questionnaire (BIQ), Food Addiction Scale (YFAS 2.0), and the Stunkard Figure Rating Scale (FRS). Objective anthropometric measurements, including body composition using InBody 270 and waist-to-hip ratio, will also be obtained.
Study summary
The purpose of this study is to examine the effects of nomophobia levels on stress, food addiction, and body image among undergraduate students aged 18-30 at Bahçeşehir University, Faculty of Health Sciences. The primary questions it aims to answer are:
* Is there a statistically significant relationship between nomophobia levels and perceived stress, food addiction, and body image among university students?
* Is there a correlation between objective anthropometric data (body fat percentage, skeletal muscle mass) measured via Bioelectrical Impedance Analysis (BIA), waist/hip circumference measurements, and the individual's perceived body image?
Eligibility
Sex
ALL
Min age
18 Years
Max age
30 Years
Healthy volunteers
No
Inclusion Criteria:
* Being an active smartphone user
* Reading and providing consent via the Informed Consent Form
* Absence of conditions such as pacemaker implantation, metallic prostheses in the body, or pregnancy
* Not having a diagnosed metabolic disorder (e.g., Cushing's syndrome, diabetes, thyroid disorders) or any acute/chronic psychiatric condition that may affect eating behavior
Exclusion Criteria:
* Individuals with a current diagnosis of an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder, etc.)
* Individuals with a psychiatric diagnosis of severe depression, bipolar disorder, psychotic disorder, or an anxiety disorder requiring treatment
* Individuals who regularly use psychiatric medications (e.g., SSRIs, SNRIs, antipsychotics, mood stabilizers, etc.)
* Individuals who have used corticosteroids or similar hormone-regulating medications in the past 3 months
* Pregnant or breastfeeding individuals
* Participants who did not complete the questionnaires or the measurement procedures
Primary outcome measure(s)
Nomophobia — Baseline The level of nomophobia experienced by participants, measured using the Nomophobia Questionnaire (NMP-Q).
This form aims to assess your feelings and thoughts when you cannot access your smartphone or are away from it, a condition known as nomophobia. There are no right or wrong answers; what matters is answering honestly based on your own experience. Indicate your level of agreement with each statement about your smartphone use (1 = strongly agree, 7 = strongly disagree).
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
